189 related articles for article (PubMed ID: 37647025)
21. METTL14 regulates CD8
Sun C; Wang J; Li H; Liu L; Lin Y; Zhang L; Zu X; Zhu Y; Shu Y; Shen D; Wang Q; Liu Y
World J Surg Oncol; 2024 May; 22(1):128. PubMed ID: 38725005
[TBL] [Abstract][Full Text] [Related]
22. LRPPRC facilitates tumor progression and immune evasion through upregulation of m
Wang H; Tang A; Cui Y; Gong H; Li H
Front Immunol; 2023; 14():1144774. PubMed ID: 37063837
[TBL] [Abstract][Full Text] [Related]
23. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
25. Sauchinone Inhibits the Proliferation and Immune Invasion Capacity of Colorectal Cancer Cells through the Suppression of PD-L1 and MMP2/MM9.
Lu Y; Yu M; Ye J; Liang Y; Gao J; Ji Z; Wang J
Anticancer Agents Med Chem; 2023; 23(12):1406-1414. PubMed ID: 36941807
[TBL] [Abstract][Full Text] [Related]
26. Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4/6 Inhibitor Through Regulation of PD-L1.
Noh JY; Lee IP; Han NR; Kim M; Min YK; Lee SY; Yun SH; Kim SI; Park T; Chung H; Park D; Lee CH
Cell Mol Gastroenterol Hepatol; 2022; 14(4):769-788. PubMed ID: 35843546
[TBL] [Abstract][Full Text] [Related]
27. S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer.
Min HY; Cho J; Sim JY; Boo HJ; Lee JS; Lee SB; Lee YJ; Kim SJ; Kim KP; Park IJ; Hong SM; Zhang XL; Zhang ZG; Park RW; Lee HY
Clin Transl Med; 2022 Jul; 12(7):e986. PubMed ID: 35858011
[TBL] [Abstract][Full Text] [Related]
28. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
29. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
Dai X; Chen K; Xie Y
Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
[TBL] [Abstract][Full Text] [Related]
30. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
31. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
32. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
[TBL] [Abstract][Full Text] [Related]
33. METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m
Cheng J; Xu Z; Tan W; He J; Pan B; Zhang Y; Deng Y
J Cell Physiol; 2024 Mar; 239(3):e31068. PubMed ID: 37357526
[TBL] [Abstract][Full Text] [Related]
34. Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells.
Hua S; Gu M; Wang Y; Ban D; Ji H
Clin Transl Oncol; 2021 Apr; 23(4):750-756. PubMed ID: 32737836
[TBL] [Abstract][Full Text] [Related]
35. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
36. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
37. METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer.
Li J; Yang F; Wang Z; Zheng S; Zhang S; Wang C; He B; Wang JB; Wang H
Cell Prolif; 2024 May; 57(5):e13590. PubMed ID: 38084791
[TBL] [Abstract][Full Text] [Related]
38. METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b.
Huang L; Liang D; Zhang Y; Chen X; Chen J; Wen C; Liu H; Yang X; Yang X; Lin S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5095-5108. PubMed ID: 36348020
[TBL] [Abstract][Full Text] [Related]
39. PD-1/PD-L1-dependent immune response in colorectal cancer.
Payandeh Z; Khalili S; Somi MH; Mard-Soltani M; Baghbanzadeh A; Hajiasgharzadeh K; Samadi N; Baradaran B
J Cell Physiol; 2020 Jul; 235(7-8):5461-5475. PubMed ID: 31960962
[TBL] [Abstract][Full Text] [Related]
40. Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.
Zheng H; Zheng WJ; Wang ZG; Tao YP; Huang ZP; Yang L; Ouyang L; Duan ZQ; Zhang YN; Chen BN; Xiang DM; Jin G; Fang L; Zhou F; Liang B
Front Immunol; 2022; 13():845193. PubMed ID: 35154166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
